Nonketotic hyperosmolar coma: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 19: Line 19:
{{EH}}
{{EH}}


==Overview==
'''Nonketotic hyperosmolar coma''' (nonketotic [[hyperglycaemia]]) is a type of [[diabetic coma]] associated with a high mortality seen in [[diabetes mellitus type 2]].  The preferred term used by the [[American Diabetes Association]] is hyperosmolar nonketotic state (HNS). Other commonly used names are hyperosmolar hyperglycemic nonketotic coma (HHNKC)<ref name="pmid1626111">{{cite journal |author=Cirasino L, Thiella G, Invernizzi R, Silvani A, Ragaini S |title=Hyperosmolar hyperglycemic nonketotic coma in Waldenström's macroglobulinemia associated with type II diabetes and complicated by pulmonary tuberculosis |journal=Recenti progressi in medicina |volume=83 |issue=4 |pages=194–6 |year=1992 |pmid=1626111 |doi=}}</ref> or hyperosmotic non-ketotic acidosis (HONK).   
'''Nonketotic hyperosmolar coma''' (nonketotic [[hyperglycaemia]]) is a type of [[diabetic coma]] associated with a high mortality seen in [[diabetes mellitus type 2]].  The preferred term used by the [[American Diabetes Association]] is hyperosmolar nonketotic state (HNS). Other commonly used names are hyperosmolar hyperglycemic nonketotic coma (HHNKC)<ref name="pmid1626111">{{cite journal |author=Cirasino L, Thiella G, Invernizzi R, Silvani A, Ragaini S |title=Hyperosmolar hyperglycemic nonketotic coma in Waldenström's macroglobulinemia associated with type II diabetes and complicated by pulmonary tuberculosis |journal=Recenti progressi in medicina |volume=83 |issue=4 |pages=194–6 |year=1992 |pmid=1626111 |doi=}}</ref> or hyperosmotic non-ketotic acidosis (HONK).   



Revision as of 16:44, 10 June 2009

Nonketotic hyperosmolar coma
ICD-9 250.2
DiseasesDB 29213
eMedicine emerg/264 
MeSH D006944

WikiDoc Resources for Nonketotic hyperosmolar coma

Articles

Most recent articles on Nonketotic hyperosmolar coma

Most cited articles on Nonketotic hyperosmolar coma

Review articles on Nonketotic hyperosmolar coma

Articles on Nonketotic hyperosmolar coma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Nonketotic hyperosmolar coma

Images of Nonketotic hyperosmolar coma

Photos of Nonketotic hyperosmolar coma

Podcasts & MP3s on Nonketotic hyperosmolar coma

Videos on Nonketotic hyperosmolar coma

Evidence Based Medicine

Cochrane Collaboration on Nonketotic hyperosmolar coma

Bandolier on Nonketotic hyperosmolar coma

TRIP on Nonketotic hyperosmolar coma

Clinical Trials

Ongoing Trials on Nonketotic hyperosmolar coma at Clinical Trials.gov

Trial results on Nonketotic hyperosmolar coma

Clinical Trials on Nonketotic hyperosmolar coma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Nonketotic hyperosmolar coma

NICE Guidance on Nonketotic hyperosmolar coma

NHS PRODIGY Guidance

FDA on Nonketotic hyperosmolar coma

CDC on Nonketotic hyperosmolar coma

Books

Books on Nonketotic hyperosmolar coma

News

Nonketotic hyperosmolar coma in the news

Be alerted to news on Nonketotic hyperosmolar coma

News trends on Nonketotic hyperosmolar coma

Commentary

Blogs on Nonketotic hyperosmolar coma

Definitions

Definitions of Nonketotic hyperosmolar coma

Patient Resources / Community

Patient resources on Nonketotic hyperosmolar coma

Discussion groups on Nonketotic hyperosmolar coma

Patient Handouts on Nonketotic hyperosmolar coma

Directions to Hospitals Treating Nonketotic hyperosmolar coma

Risk calculators and risk factors for Nonketotic hyperosmolar coma

Healthcare Provider Resources

Symptoms of Nonketotic hyperosmolar coma

Causes & Risk Factors for Nonketotic hyperosmolar coma

Diagnostic studies for Nonketotic hyperosmolar coma

Treatment of Nonketotic hyperosmolar coma

Continuing Medical Education (CME)

CME Programs on Nonketotic hyperosmolar coma

International

Nonketotic hyperosmolar coma en Espanol

Nonketotic hyperosmolar coma en Francais

Business

Nonketotic hyperosmolar coma in the Marketplace

Patents on Nonketotic hyperosmolar coma

Experimental / Informatics

List of terms related to Nonketotic hyperosmolar coma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Nonketotic hyperosmolar coma (nonketotic hyperglycaemia) is a type of diabetic coma associated with a high mortality seen in diabetes mellitus type 2. The preferred term used by the American Diabetes Association is hyperosmolar nonketotic state (HNS). Other commonly used names are hyperosmolar hyperglycemic nonketotic coma (HHNKC)[1] or hyperosmotic non-ketotic acidosis (HONK).

Pathophysiology

Nonketotic coma is usually precipitated by an acute illness, myocardial infarction or stroke. A relative insulin deficiency leads to a serum glucose that is usually higher than 33mmol/l (600 mg/dl), and a resulting serum osmolarity that is greater than 350 mOsm. This leads to polyuria (an osmotic diuresis), which, in turn, leads to volume depletion and hemoconcentration that causes a further increase in blood glucose level. Ketosis is absent because the presence of some insulin inhibits lipolysis, unlike diabetic ketoacidosis.

Clinical presentation

Template:Diabetes The increasing hemoconcentration and volume depletion may result in:

  • Hyperviscosity and increased risk of thrombosis
  • Disturbed mentation
  • Neurologic signs including focal signs such as sensory or motor impairments or focal seizures or motor abnormalities, including flacidity, depressed reflexes, tremors or fasciculations.
  • Ultimately, if untreated, will lead to death.

Treatment

The treatment involves slow hydration, replacement of electrolytes and intravenous insulin. Anticoagulants (such as low molecular weight heparins) are often commenced as there is a significant rate of thrombosis in patients with NKHC.

References

  1. Cirasino L, Thiella G, Invernizzi R, Silvani A, Ragaini S (1992). "Hyperosmolar hyperglycemic nonketotic coma in Waldenström's macroglobulinemia associated with type II diabetes and complicated by pulmonary tuberculosis". Recenti progressi in medicina. 83 (4): 194–6. PMID 1626111.

Template:SIB

Template:WH Template:WikiDoc Sources